Offer - Urjas Oil for just ₹ 1
StayHappi Brimonidine Tartrate + Timolol Eye Drop is an allopathic medicine The correct dosage of StayHappi Brimonidine Tartrate + Timolol Eye Drop depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Brimonidine Tartrate + Timolol Eye Drop is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Is the use of StayHappi Brimonidine Tartrate + Timolol Eye Drop safe for pregnant women?
StayHappi Brimonidine Tartrate + Timolol Eye Drop can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking StayHappi Brimonidine Tartrate + Timolol Eye Drop right away. Take your doctor's advice before taking it again.
Is the use of StayHappi Brimonidine Tartrate + Timolol Eye Drop safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of StayHappi Brimonidine Tartrate + Timolol Eye Drop. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of StayHappi Brimonidine Tartrate + Timolol Eye Drop on the Kidneys?
Very few cases of side effects of StayHappi Brimonidine Tartrate + Timolol Eye Drop on kidney have been reported.
What is the effect of StayHappi Brimonidine Tartrate + Timolol Eye Drop on the Liver?
Side effects of StayHappi Brimonidine Tartrate + Timolol Eye Drop rarely affect the liver.
What is the effect of StayHappi Brimonidine Tartrate + Timolol Eye Drop on the Heart?
StayHappi Brimonidine Tartrate + Timolol Eye Drop has very mild side effects on the heart.
StayHappi Brimonidine Tartrate + Timolol Eye Drop should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take StayHappi Brimonidine Tartrate + Timolol Eye Drop unless your doctor advises you to do so -
Is this StayHappi Brimonidine Tartrate + Timolol Eye Drop habit forming or addictive?
Forming a habit of StayHappi Brimonidine Tartrate + Timolol Eye Drop has not been reported.
Interaction between Food and StayHappi Brimonidine Tartrate + Timolol Eye Drop
Due to the absence of research, it is difficult to say how StayHappi Brimonidine Tartrate + Timolol Eye Drop and food will interact.
Interaction between Alcohol and StayHappi Brimonidine Tartrate + Timolol Eye Drop
Consumption of alcohol and StayHappi Brimonidine Tartrate + Timolol Eye Drop together may have severe effects on your health.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1405
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 154
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alphagan® (brimonidine tartrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Simbrinza™ (brinzolamide/brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Enidin® (brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Alphagan® P (brimonidine tartrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Istalol® (timolol maleate ophthalmic solution)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1401
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 153
